Cargando…
Efficient gene correction of an aberrant splice site in β‐thalassaemia iPSCs by CRISPR/Cas9 and single‐strand oligodeoxynucleotides
β‐thalassaemia is a prevalent hereditary haematological disease caused by mutations in the human haemoglobin β (HBB) gene. Among them, the HBB IVS2‐654 (C > T) mutation, which is in the intron, creates an aberrant splicing site. Bone marrow transplantation for curing β‐thalassaemia is limited due...
Autores principales: | Xiong, Zeyu, Xie, Yingjun, Yang, Yi, Xue, Yanting, Wang, Ding, Lin, Shouheng, Chen, Diyu, Lu, Dian, He, Lina, Song, Bing, Yang, Yinghong, Sun, Xiaofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850948/ https://www.ncbi.nlm.nih.gov/pubmed/31631510 http://dx.doi.org/10.1111/jcmm.14669 |
Ejemplares similares
-
The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice
por: Xian, Yexing, et al.
Publicado: (2020) -
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014) -
iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017) -
Disruption of splicing-regulatory elements using CRISPR/Cas9 to rescue spinal
muscular atrophy in human iPSCs and mice
por: Li, Jin-Jing, et al.
Publicado: (2020) -
Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A
por: Hiramoto, Takafumi, et al.
Publicado: (2023)